AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 191 filers reported holding AMICUS THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 0.71 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $413,926 | -48.2% | 34,040 | -46.5% | 0.05% | -63.6% |
Q2 2023 | $798,540 | +591.1% | 63,578 | +510.2% | 0.13% | +450.0% |
Q1 2023 | $115,547 | -58.0% | 10,419 | -60.4% | 0.02% | -56.4% |
Q3 2022 | $275,000 | +18.0% | 26,303 | +6.7% | 0.06% | +77.4% |
Q1 2022 | $233,000 | -27.9% | 24,651 | -11.8% | 0.03% | -46.6% |
Q4 2021 | $323,000 | +115.3% | 27,934 | +77.9% | 0.06% | +314.3% |
Q3 2021 | $150,000 | -71.3% | 15,700 | -30.5% | 0.01% | -88.3% |
Q1 2021 | $522,000 | 0.0% | 22,603 | 0.0% | 0.12% | +0.8% |
Q4 2020 | $522,000 | +155.9% | 22,603 | +56.4% | 0.12% | +170.5% |
Q3 2020 | $204,000 | +25.9% | 14,454 | +34.4% | 0.04% | -63.0% |
Q2 2020 | $162,000 | -83.9% | 10,754 | -83.9% | 0.12% | +43.4% |
Q1 2018 | $1,004,000 | -48.4% | 66,755 | -50.6% | 0.08% | -58.1% |
Q4 2017 | $1,944,000 | +11.4% | 135,100 | +16.8% | 0.20% | -7.0% |
Q3 2017 | $1,745,000 | +21712.5% | 115,700 | +14362.5% | 0.21% | +21200.0% |
Q2 2017 | $8,000 | – | 800 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Redmile Group, LLC | 21,719,191 | $226,748,000 | 8.80% |
Perceptive Advisors | 27,372,917 | $285,773,000 | 8.29% |
Palo Alto Investors LP | 9,847,774 | $102,811,000 | 8.13% |
Finepoint Capital LP | 1,688,400 | $17,627,000 | 5.80% |
CM Management, LLC | 450,000 | $4,698,000 | 5.24% |
Avoro Capital Advisors LLC | 26,800,000 | $279,792,000 | 5.17% |
Artal Group S.A. | 4,000,000 | $41,760,000 | 1.78% |
Kynam Capital Management, LP | 676,849 | $7,066,000 | 1.49% |
Ghost Tree Capital, LLC | 500,000 | $5,220,000 | 1.46% |
Boxer Capital, LLC | 2,325,000 | $24,273,000 | 1.36% |